These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2090 related items for PubMed ID: 8923836

  • 1. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [Abstract] [Full Text] [Related]

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Apr; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 4. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
    [Abstract] [Full Text] [Related]

  • 5. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 6. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, Minuto F.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
    Boguszewski M, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
    [Abstract] [Full Text] [Related]

  • 8. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [Abstract] [Full Text] [Related]

  • 9. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [Abstract] [Full Text] [Related]

  • 10. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA, Stijnen T, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [Abstract] [Full Text] [Related]

  • 11. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 12. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG, Braslavsky D, Scaglia PA, Keselman A, Rodríguez ME, Martínez A, Freire AV, Domené HM, Jasper HG, Bergadá I, Ropelato MG.
    Horm Res Paediatr; 2017 Aug; 88(5):354-363. PubMed ID: 28926833
    [Abstract] [Full Text] [Related]

  • 13. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M, Mulder P, Houdijk M, Mulder J, Noordam K, Odink RJ, Rongen-Westerlaken C, Voorhoeve P, Waelkens J, Stokvis-Brantsma J, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [Abstract] [Full Text] [Related]

  • 14. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.
    Binder G, Seidel AK, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Eggermann T, Ranke MB.
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1402-7. PubMed ID: 18230663
    [Abstract] [Full Text] [Related]

  • 15. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 16. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 17. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC, Rose SR, van Dijk M, Noordam C, van Rheenen E, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [Abstract] [Full Text] [Related]

  • 18. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC, Hendriks AE, Ester WA, Leunissen RW, Willemsen RH, de Kort SW, Paquette JR, Hokken-Koelega AC, Deal CL.
    Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.
    Renes JS, de Ridder MA, Breukhoven PE, Lem AJ, Hokken-Koelega AC.
    PLoS One; 2012 Jun; 7(12):e53164. PubMed ID: 23300884
    [Abstract] [Full Text] [Related]

  • 20. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.